Jessica Perego, PhD
Founder & CEO
Jessica leads the scientific and product vision, bringing expertise in neuroimmunology, the microbiome and the gut–brain axis to research on neurological conditions.
LinkedIn ↗OUR STORY & SCIENCE
Curiosity brought us here.
Evidence takes us forward.
NeuraBI began with a question: could a better understanding of the gut microbiome help us look at neurological care differently?
In development · Recruitment openA small team.
A shared scientific question.
We bring together microbiome science, business development and artificial intelligence. Our work is at an early stage, and we investigate carefully before we claim anything.
The people behind the questions.
am.
Aurélia Martinez, MBA
Co-CEO & Directrice Générale
Aurélia leads company development and operations, strategic partnerships and execution, connecting the scientific vision with the organisation needed to deliver it.
Bhoumik Shankar Mishra
Co-founder & AI/ML Lead
Bhoumik leads AI and machine learning, computational modelling, data integration and technical development across the platform and its portals.
LinkedIn ↗OUR JOURNEY
Where we are,
and what comes next.
Four milestones, from the prototype that exists today to a service that would follow validation. Timing depends on research findings, partnerships and the necessary approvals.
- ✓DONE SO FAR
A working prototype
The analysis workflow, patient portal and clinician review have been implemented and tested with synthetic examples. This is software testing, not clinical validation.
- WE ARE HERE
Preparing the pilot
Agreeing the study protocol, laboratory arrangements and clinical input, and preparing for the required approvals.
- NEXT
Learn from a first study
Run the pilot once approved, with follow-up and repeat samples, to find out whether this is feasible and useful.
- LONGER TERM
Prove it before offering it
Further validation and any regulatory steps would come before a service could become available.
What the current prototype uses.
Study reference
The MS example uses 460 development household controls from the public iMSMS cohort. MS cases and the locked internal test set were not used to fit these reference intervals.
Selected measurements
The public example compares 54 measurements: 47 bacterial species and 7 gene pathways. Pathways describe functional potential, not measured metabolite concentrations.
Comparison method
The model estimates the 10th–90th percentiles, accounting for age, recorded sex and BMI. This central 80% interval is a study comparison, not a clinically established healthy target.
What remains to be shown
The portal demonstrates the software workflow. Independent validation, processing compatibility and prospective clinical usefulness still require evaluation.
imsms-module1-expanded-reporting-reference-v1
THE SCIENCE, SIMPLY
Two organs.
One conversation.
Your gut does more than digest food. It is part of a network of signals that connects with your brain. Researchers call this the gut–brain axis.
Always in conversation
Drag to rotate · Tap a label to exploreTap a label to exploreExplore the three pathways
01 / 03
A direct line of communication.
Nerves, including the vagus nerve, carry messages between the gut and the brain. Communication travels in both directions.
02 / 03
A shared conversation with the immune system.
The gut, its microorganisms and the immune system interact. Scientists are studying how these signals relate to processes in the brain.
03 / 03
Small molecules. Interesting questions.
Gut microorganisms help break down food and produce molecules called metabolites. Researchers are exploring how these molecules interact with the body and brain.
Understanding a connection is where research begins. NeuraBI is a research project, and nothing on this website is a way to prevent, diagnose or treat a condition.
Explore the scienceTHE SCIENCE, SIMPLY
The science behind
the question.
A growing field of research, with important unanswered questions. These publications are the background to our question. NeuraBI’s own evidence has still to come from its studies.
REVIEW · 2024
Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases
A review of communication pathways and preclinical and clinical research. It highlights a field to investigate, not a proven NeuraBI intervention.
Read the publicationOBSERVATIONAL RESEARCH · 2022
Gut microbiome of multiple sclerosis patients and paired household healthy controls
Research into associations between the microbiome and multiple sclerosis. An association alone does not establish causation or clinical usefulness.
Read the publicationTHE NEXT CHAPTER STARTS WITH A QUESTION.
Let’s understand
more, together.
A clinician, a researcher, a patient organisation, or simply curious? We’d like to hear from you.
Get in touchClinical advisor opportunity
Work with us
Help shape the clinical future of personalised brain health.
NeuraBI is developing AI-powered, personalised microbiome-based approaches for neurological and neuropsychiatric disorders, with an initial focus on multiple sclerosis, Parkinson’s disease and Alzheimer’s disease.
Clinical Advisor — Neurology
Support the clinical development of our AI-powered platform for microbiome-informed precision medicine.
What you will contribute
- Clinical strategy
- Clinical validation
Your background
- Medical degree (MD or equivalent) with specialisation in neurology or ongoing neurology residency.
- Interest in the gut–brain axis, microbiome research and precision medicine.
- Experience in clinical trials, translational research or AI in healthcare is a plus.
Scientific collaboration
Scientific collaboration and co-authorship opportunities.